Sandbox3: Difference between revisions

Jump to navigation Jump to search
(Created page with "==Management== {{familytree/start |summary=Acute Pancreatitis}} {{familytree | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | |A01='''Signs & symptoms''': severe abd...")
 
 
Line 4: Line 4:
{{familytree | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | |A01='''Signs & symptoms''': severe abdominal pain, breathing difficulty, hypotension, vomiting, fever, [[cullen's sign]], [[grey turner sign]]}}
{{familytree | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | |A01='''Signs & symptoms''': severe abdominal pain, breathing difficulty, hypotension, vomiting, fever, [[cullen's sign]], [[grey turner sign]]}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | E01 | | | | | UNSTABLE| | | | E02 | |E01=Hemodynamic stability?|EO2=Need to create hyperlink here}}
{{familytree | | | | | | | | | | | | | E01 | | | | | E02 | | | | E03 | |E01=Hemodynamic stability? |E02=Unstable |EO3=Need to create hyperlink here}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree |border=0| | | | | | | | | | | | | Z01 | Z01 = Stable }}  
{{familytree |border=0 | | | | | | | | | | | | | Z01 | Z01 = Stable }}  
{{familytree | | | | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| | | | | | | | |}}
{{familytree | | | | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| | | | | | | | |}}
{{familytree | | | | | | B01 | | | | | | | | | | | | B02 | | | | | | | |B01=Trans abdominal USG|B02='''Labs''': BUN, CBC, CXR, HCT, serum amylase, serum lipase, serum triglycerides, sr. creatinine}}
{{familytree | | | | | | B01 | | | | | | | | | | | | B02 | | | | | | | |B01=Trans abdominal USG |B02='''Labs''': BUN, CBC, CXR, HCT, serum amylase, serum lipase, serum triglycerides, sr. creatinine}}
{{familytree | | | | | | |`|-|-|-|-|-|-|v|-|-|-|-|-|-|'| | | | | | | | |}}
{{familytree | | | | | | |`|-|-|-|-|-|-|v|-|-|-|-|-|-|'| | | | | | | | |}}
{{familytree | | | | | | | | | | | | | C01 | | | | | | | | | | | | | | |C01='''Diagnostic criteria''': Any 2 out of 3<br><br> Abdominal pain consistent with disease<br><br>serum amylase or lipase values > 3 times normal<br><br>consistent findings from abdominal imaging}}
{{familytree | | | | | | | | | | | | | C01 | | | | | | | | | | | | | | |C01='''Diagnostic criteria''': Any 2 out of 3<br><br> Abdominal pain consistent with disease<br><br>serum amylase or lipase values > 3 times normal<br><br>consistent findings from abdominal imaging}}
Line 16: Line 16:
{{familytree | | | | | | | | | | | | | F01 | | | | | | yes |-|.| | | | |F01=SIRS? }}
{{familytree | | | | | | | | | | | | | F01 | | | | | | yes |-|.| | | | |F01=SIRS? }}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | |!| | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | |!| | | | |}}
{{familytree |border=0 | | | | | | | | NO | | | | | | | | | |!| | | | |}}
{{familytree |border=0 | | | | | | | | | | | | | AA1 | | | | | | | | | |!| | | | |AA1=No}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | |!| | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | |!| | | | |}}
{{familytree | | | | | | | | | | | | | G01 | | | | | | | | | |!| | | | |G01=Risk stratification (Marshall scoring)}}
{{familytree | | | | | | | | | | | | | G01 | | | | | | | | | |!| | | | |G01=Risk stratification (Marshall scoring)}}
{{familytree | | | | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| | | |!| | | | |}}
{{familytree | | | | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| | | |!| | | | |}}
{{familytree | | | | | | H01 | | | | | | | | | | | | H02 | | |!| | | | |H01=Lower risk|H02=Higher risk}}
{{familytree | | | | | | H01 | | | | | | | | | | | | H02 | | |!| | | | |H01=Lower risk |H02=Higher risk}}
{{familytree | | | | | | |!| | | | | | | | | | | | | |!| | | |!| | | | |}}
{{familytree | | | | | | |!| | | | | | | | | | | | | |!| | | |!| | | | |}}
{{familytree | | | | | | I01 | | | | | | | | | | | | I02 |-|-|'| | | | |I01= Admit to medical ward |I02=Admit to ICU}}
{{familytree | | | | | | I01 | | | | | | | | | | | | I02 |-|-|'| | | | |I01= Admit to medical ward |I02=Admit to ICU}}
{{familytree | | | | | | |!| | | | | | | | | | | | | |!| | | | | | | | |}}
{{familytree | | | | | | |!| | | | | | | | | | | | | |!| | | | | | | | |}}
{{familytree | | | | | | J01 | | | | | | | | | | | | J02 | | | | | | | |J01= Fluids: Aggressive hydration at 250-500 ml/hr with Ringer's lactate in first 12-24 hrs <br> Reassess within 6 hrs after admission and for next 24-48 hrs <br><br> Analgesics: Opioids are preferred, Mepridine & Morphine may be used as IV drips/pt. controlled analgesia <br><br> Nutrition: Immediate oral feeding as soon as pain, vomiting, nausea subside
{{familytree | | | | | | J01 | | | | | | | | | | | | J02 | | | | | | | |J01= Fluids: Aggressive hydration at 250-500 ml/hr with Ringer's lactate in first 12-24 hrs <br> Reassess within 6 hrs after admission and for next 24-48 hrs <br><br> Analgesics: Opioids are preferred, Mepridine & Morphine may be used as IV drips/pt. controlled analgesia <br><br> Nutrition: Immediate oral feeding as soon as pain, vomiting, nausea subside |J02=Fluids: Initiate with a fluid bolus<br> Aggressive hydration at 250-500 ml/hr with Ringer's lactate in first 12-24 hrs <br> Reassess within 6 hrs after admission and for next 24-48 hrs <br><br>Analgesics: Opioids are preferred, Mepridine & Morphine may be used as IV drips/pt. controlled analgesia <br><br> Nutrition: Nasogastric or nasojejunal feeding may be initiated once pain, vomiting, nausea subside <br> Consider enteral feeding if above not tolerated}}
(strong recommendation, moderate quality of evidence). |JO2=}}
{{familytree | | | | | | |`|-|-|-|-|-|-|v|-|-|-|-|-|-|'| | | | | | | | |}}
{{familytree | | | | | | |`|-|-|-|-|-|-|v| |-|-|-|-|-|'| | | | | | | | |}}
{{familytree | | | | | | | | | | | | | K01 |-|-|-|-|-| YES |-|-|-|-| K02 |K01=Cholangitis or biliary obstruction |K02=ERCP within 24 hrs/Cholecystectomy to prevent recurrence }}
{{familytree | | | | | | | | | | | | | K01 |-|-|-|-|-| YES |-|-|-|-| K02 |K01=|K02=}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | NO  | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | L01 | | | | | | | | | | | | | | |L01=}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | M01 |-|-|-|-|-| YES |-|-|-|-| M02 |M01=|MO2=}}
{{familytree |border=0 | | | | | | | | | | | | | AK1 | | | | | | | | |AK1=No | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | NO  | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | L01 | | | | | | | | | | | | | | |L01=Consider MRCP/EUS}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | N01 | | | | | | | | | | | | | | |N01=}}
{{familytree | | | | | | | | | | | | | M01 |-|-|-|-|-| YES |-|-|-|-| M02 |M01=Clinical improvement within 48-72 hrs |M02=Assess for ability to maintain oral feeding at the end of 1 week}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |!|}}
{{familytree |border=0 | | | | | | | | | | | | | AE1 | | | |AE1=N o  | | | | | | | | | | |!|}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |!|}}
{{familytree | | | | | | | | | | | | | N01 | | | | | | | | | | | | | N02 | | | | |N01=CECT/MRI |N02=Recovery}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | O01 | | | | | | | | | | | | | | |O01=}}
{{familytree | | | | | | | | | | | | | O01 | | | | | | | | | | | | | | |O01=Pancreatic necrosis}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | P01 |-|-|-|-|-| YES |-|-|-|-| P02 |P01=|P02=}}
{{familytree | | | | | | | | | | | | | P01 |-|-|-|-|-| P02 |-|-|-|-| P03 |P01=Failure to improve clinically after 7-10 days of hospitalization|P02=Yes|P03=Supportive treatment|}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | NO  | | | | | | | | | | | | | | |}}
{{familytree |border=0 | | | | | | | | | | || | AF1 | | | | |AF1=No | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | Q01 | | | | | | | | | | | | | | |Q01=}}
{{familytree | | | | | | | | | | | | | Q01 | | | | | | | | | | | | | | |Q01=Suspect Infected necrosis}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | R01 | | - | | R02 |-|-|-|-| R03 |R01=|R02=|R03=}}
{{familytree | | | | | | | | | | | | | R01 |-|-|-|-| R02 |-|-|-|-| R03 |R01=CT guided FNA <br><br> Empiric antibiotics, necrosis penetrating: <br><br>meropenem 1g IV Q8h <br><br> ciprofloxacin 400mg IV Q12h plus metronidazole 500 mg IV Q8h for 14 days |R02=Gram stain & Culture (-) |R03=Supportive treatment<br> Consider repeat CT FNA every 7 days if no improvement }}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | |  + | | | | | | | | | | | | | |}}
{{familytree |border=0 | | | | | | | | | | | | | |  AG1 | | | | | | |AG1=Gram stain & Culture(+) | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | S01 | | | | | | | | | | | | | | |S01=}}
{{familytree | | | | | | | | | | | | | S01 | | | | | | | | | | | | | | |S01=Infected Necrosis}}
{{familytree | | | | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| | | | | | | | |}}
{{familytree | | | | | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| | | | | | | | |}}
{{familytree | | | | | | T01 | | | | | | | | | | | | T02 | | | | | | | |T01=|T02=}}
{{familytree | | | | | | T01 | | | | | | | | | | | | T02 | | | | | | | |T01=Clinically stable|T02=Clinically unstable}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | |!| | | | | | | | | | | | | |!| | | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | U01 | | | | | | | | | | | | U02 | | | | | | | |U01=Continue antibiotics & observe <br> If asymptomatic no debridement, else consider surgical consultation |U02=Prompt surgical consultation}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}}
{{familytree/end}}
{{familytree/end}}
* * - Low risk: 1. Absence of organ failure. and/or 2. Absence of local complications
* ** - High risk: 1. Transient organ failure. and/or 2. local complications.
The following recommendations are based on 2013 guidelines for Acute pancreatitis treatment based on recommendations given by American college of gastroenterology.<ref name="Tenner-2013">{{Cite journal  | last1 = Tenner | first1 = S. | last2 = Baillie | first2 = J. | last3 = DeWitt | first3 = J. | last4 = Vege | first4 = SS. | title = American College of Gastroenterology guideline: management of acute pancreatitis. | journal = Am J Gastroenterol | volume = 108 | issue = 9 | pages = 1400-15; 1416 | month = Sep | year = 2013 | doi = 10.1038/ajg.2013.218 | PMID = 23896955 }}</ref>

Latest revision as of 16:17, 7 December 2013

Management

 
 
 
 
 
 
 
 
 
 
 
 
Signs & symptoms: severe abdominal pain, breathing difficulty, hypotension, vomiting, fever, cullen's sign, grey turner sign
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hemodynamic stability?
 
 
 
 
Unstable
 
 
 
{{{ E03 }}}
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stable
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Trans abdominal USG
 
 
 
 
 
 
 
 
 
 
 
Labs: BUN, CBC, CXR, HCT, serum amylase, serum lipase, serum triglycerides, sr. creatinine
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagnostic criteria: Any 2 out of 3

Abdominal pain consistent with disease

serum amylase or lipase values > 3 times normal

consistent findings from abdominal imaging
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acute Pancreatitis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SIRS?
 
 
 
 
 
{{{ yes }}}
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Risk stratification (Marshall scoring)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lower risk
 
 
 
 
 
 
 
 
 
 
 
Higher risk
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Admit to medical ward
 
 
 
 
 
 
 
 
 
 
 
Admit to ICU
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fluids: Aggressive hydration at 250-500 ml/hr with Ringer's lactate in first 12-24 hrs
Reassess within 6 hrs after admission and for next 24-48 hrs

Analgesics: Opioids are preferred, Mepridine & Morphine may be used as IV drips/pt. controlled analgesia

Nutrition: Immediate oral feeding as soon as pain, vomiting, nausea subside
 
 
 
 
 
 
 
 
 
 
 
Fluids: Initiate with a fluid bolus
Aggressive hydration at 250-500 ml/hr with Ringer's lactate in first 12-24 hrs
Reassess within 6 hrs after admission and for next 24-48 hrs

Analgesics: Opioids are preferred, Mepridine & Morphine may be used as IV drips/pt. controlled analgesia

Nutrition: Nasogastric or nasojejunal feeding may be initiated once pain, vomiting, nausea subside
Consider enteral feeding if above not tolerated
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cholangitis or biliary obstruction
 
 
 
 
 
{{{ YES }}}
 
 
 
 
ERCP within 24 hrs/Cholecystectomy to prevent recurrence
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consider MRCP/EUS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clinical improvement within 48-72 hrs
 
 
 
 
 
{{{ YES }}}
 
 
 
 
Assess for ability to maintain oral feeding at the end of 1 week
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N o
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CECT/MRI
 
 
 
 
 
 
 
 
 
 
 
 
Recovery
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pancreatic necrosis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Failure to improve clinically after 7-10 days of hospitalization
 
 
 
 
 
Yes
 
 
 
 
Supportive treatment
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Suspect Infected necrosis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CT guided FNA

Empiric antibiotics, necrosis penetrating:

meropenem 1g IV Q8h

ciprofloxacin 400mg IV Q12h plus metronidazole 500 mg IV Q8h for 14 days
 
 
 
 
Gram stain & Culture (-)
 
 
 
 
Supportive treatment
Consider repeat CT FNA every 7 days if no improvement
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gram stain & Culture(+)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Infected Necrosis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clinically stable
 
 
 
 
 
 
 
 
 
 
 
Clinically unstable
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Continue antibiotics & observe
If asymptomatic no debridement, else consider surgical consultation
 
 
 
 
 
 
 
 
 
 
 
Prompt surgical consultation